Brind.

Wyatt Gotbetter was appointed to several senior roles, including President of market access, involving PAREXEL, Cytel, and Biogen.

1 report, 1 independent Updated Sep 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Wyatt Gotbetter was appointed to several senior roles, including President of market access, involving PAREXEL, Cytel, and Biogen.

Who's involved

What this event is mainly about
PAREXELCytelBiogen

Keep exploring

The entities involved

  • PAREXEL

    American biopharmaceutical company

    Nothing else this week.

  • Cytel

    Contract research organization

    Nothing else this week.

  • Biogen

    American multinational biotechnology company

    Nothing else this week.

Coverage

Newest first; wire copies grouped